Association of intraductal carcinoma of the prostate detected by initial histological specimen and neuroendocrine prostate cancer: A report of three cases

被引:2
|
作者
Ikeda, Junichi [1 ,2 ]
Ohe, Chisato [1 ]
Ohsugi, Haruyuki [2 ]
Matsuda, Tadashi [2 ]
Tsuta, Koji [1 ]
Kinoshita, Hidefumi [2 ]
机构
[1] Kansai Med Univ, Dept Pathol, 2-3-1 Shin Machi, Hirakata, Osaka 5731191, Japan
[2] Kansai Med Univ, Dept Urol & Androl, Hirakata, Osaka, Japan
关键词
androgen deprivation therapy; immunohistochemistry; intraductal carcinoma of the prostate; neuroendocrine prostate cancer; NEEDLE-BIOPSY; FEATURES; ADENOCARCINOMA;
D O I
10.1111/pin.13137
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We present three cases of neuroendocrine prostate cancer (NEPC) and histologically investigate the association of intraductal carcinoma of the prostate (IDC-P) and NEPC. Case 1 was a 76-year-old man who had NEPC identified by repeated biopsy specimens when his prostate-specific antigen (PSA) level became elevated 8 years after the initiation of androgen deprivation therapy (ADT). Case 2 was a 70-year-old man who had NEPC detected when multiple bone metastases were found 3 years after the initiation of ADT. Case 3 was a 70-year-old man who was diagnosed with NEPC based on histological examination of transurethral resected specimens. The histological findings in these three cases showed mixed neuroendocrine carcinoma-acinar adenocarcinoma with various proportions of both components. In all three cases, the neuroendocrine carcinoma components were positive for synaptophysin and chromogranin A, whereas the adenocarcinoma components were positive for PSA and NKX3.1. When we retrospectively reviewed the initial hematoxylin and eosin-stained slides, IDC-P was detected in all three cases. Furthermore, we collected nine additional cases of NEPC and found that all six cases with initial biopsy specimens available had an IDC-P component. Detecting IDC-P on initial histological specimens of the prostate may predict transformation to NEPC.
引用
收藏
页码:621 / 626
页数:6
相关论文
共 50 条
  • [1] Isolated Intraductal Carcinoma of the Prostate in Prostatectomy Specimens: Report of 2 Cases and Review of the Literature
    Grypari, Ioanna Maria
    Logotheti, Souzana
    Lazaris, Andreas C.
    Kallidonis, Panagiotis
    Fokaefs, Eleutherios
    Melachrinou, Maria
    Zolota, Vasiliki
    Tzelepi, Vasiliki
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2020, 28 (08) : 918 - 924
  • [2] Intraductal carcinoma of the prostate: Precursor or aggressive phenotype of prostate cancer?
    Bonkhoff, Helmut
    Wheeler, Thomas M.
    van der Kwast, Theodorus H.
    Magi-Galluzzi, Cristina
    Montironi, Rodolfo
    Cohen, Ronald J.
    PROSTATE, 2013, 73 (04) : 442 - 448
  • [3] The presence and clinical implication of intraductal carcinoma of prostate in metastatic castration resistant prostate cancer
    Chen, Zhibin
    Chen, Ni
    Shen, Pengfei
    Gong, Jing
    Li, Xiang
    Zhao, Tao
    Liao, Banghua
    Liu, Liangren
    Liu, Zhenhua
    Zhang, Xingming
    Liu, Jiyan
    Peng, Zhufeng
    Chen, Xueqin
    Xu, Miao
    Gui, Haojun
    Zhang, Peng
    Wei, Qiang
    Zhou, Qiao
    Zeng, Hao
    PROSTATE, 2015, 75 (12) : 1247 - 1254
  • [4] Intraductal Carcinoma of the Prostate as a Cause of Prostate Cancer Metastasis: A Molecular Portrait
    Pantazopoulos, Helen
    Diop, Mame-Kany
    Grosset, Andree-Anne
    Rouleau-Gagne, Frederique
    Al-Saleh, Afnan
    Boblea, Teodora
    Trudel, Dominique
    CANCERS, 2022, 14 (03)
  • [5] Comedonecrosis Revisited Strong Association With Intraductal Carcinoma of the Prostate
    Fine, Samson W.
    Al-Ahmadie, Hikmat A.
    Chen, Ying-Bei
    Gopalan, Anuradha
    Tickoo, Satish K.
    Reuter, Victor E.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (08) : 1036 - 1041
  • [6] Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate
    Yamamoto, Akiyuki
    Kato, Masashi
    Matsui, Hirotaka
    Ishida, Ryo
    Kimura, Tohru
    Funahashi, Yasuhito
    Sassa, Naoto
    Matsukawa, Yoshihisa
    Kamihira, Osamu
    Hattori, Ryohei
    Gotoh, Momokazu
    Tsuzuki, Toyonori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (03) : 584 - 590
  • [7] Presence of corpora amylacea among prostate cancer cells: an unrecognised feature of intraductal carcinoma of the prostate
    Sugie, Miho
    Takahara, Taishi
    Ohashi, Akiko
    Sassa, Naoto
    Tsuzuki, Toyonori
    PATHOLOGY, 2021, 53 (05) : 574 - 578
  • [8] MRI-detectability and histological factors of prostate cancer including intraductal carcinoma and cribriform pattern
    Mikoshi, Ayako
    Miyai, Kosuke
    Hamabe, Fumiko
    Edo, Hiromi
    Ito, Keiichi
    Matsukuma, Susumu
    Tsuda, Hitoshi
    Shinmoto, Hiroshi
    PROSTATE, 2022, 82 (04) : 452 - 463
  • [9] Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort study
    Watts, Katherine
    Li, Jianbo
    Magi-Galluzzi, Cristina
    Zhou, Ming
    HISTOPATHOLOGY, 2013, 63 (04) : 574 - 579
  • [10] Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy?
    Yun, Bu Hyeon
    Hwang, Eu Chang
    Yu, Ho Song
    Chung, Hoseok
    Kim, Sun-Ouck
    Jung, Seung Il
    Kang, Taek Won
    Kwon, Dong Deuk
    Park, Kwangsung
    Choi, Chan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (08) : 1251 - 1257